Emilie Gysel

Emilie Gysel

Auto-generated profile, based on publicly available information

Emilie Gysel

Pharmaceutical Production Research Facility (PPRF), University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JCJames Colter
James Colter
TDTiffany Dang
Tiffany Dang
EGEmilie Gysel
Emilie Gysel
DYDaniel Young
Daniel Young
ADAntoine Dufour
Antoine Dufour
MKMichael S Kallos
Michael S Kallos
Despite accelerating interest in using human induced pluripotent stem cell (hiPSC)–derived products for disease modeling and therapeutic development, there is substantial evidence that conventional culture approaches do not fully recapitulate natural embryonic nor lineage-committed states. It remains poorly understood how in vitro environmental conditions cause divergence from natural developmental trajectories, and current strategies emphasize restricted characterization of phenotype without appreciating the complexity of biology in maintaining pluripotency and driving differentiation. To address this knowledge gap, we examined hiPSC cell state during short-term culture in stirred-suspension bioprocesses under varying oxygen and agitation conditions. We profiled intracellular metabolic, transcriptional, and proteomic changes to characterize cellular responses to engineered environments and implications for cell phenotype. Using a random forest framework, we modeled population dynamics over time across metabolic and transcriptional programs and mapped those predictions onto hallmark biological signatures. This integrative approach captures and identifies environmentally reinforced programs, offering a framework to guide optimization of pluripotent cell state maintenance and differentiation.